Atorvastatin Brand Availability & Sales in India 🇮🇳

This presentation provides a comprehensive analysis of the pharmaceutical market, covering market share, strength preferences, pricing differentials, and distribution channels. Key highlights include market dominance by Cipla, Lupin, and Zydus (75.7%), strong preference for mid-range strengths (10mg, 20mg, 40mg), and the prominence of S2 Pharmacy in distribution. Strategic insights suggest leveraging dominant channels, addressing pricing anomalies, and enhancing mid-range strength offerings...